Mainstream

Metsera ultra-long acting GLP-1 MET-097i excels in mid-stage trial

Metsera ultra-long acting GLP-1 MET-097i excels in mid-stage trial

Post Contentmtsr, pfeRead More

You might also be interested in reading In 22 Days, Liquid Staking Platforms Witness a 340,000 ETH Decline.

September 29, 2025
In Mainstream